Biotechnology – Page 2

MeiraGTx and Hologen AI Form $430M Collaboration to Advance Parkinson’s Gene Therapy

4 months ago talkbio0Tagged Artificial Intelligence, Biotechnology, Clinical Trials, gene therapy, Parkinson 's disease

gene therapy, Parkinson’s disease, artificial intelligence, clinical trials, biotechnology partnership

Nimbus Therapeutics Announces Leadership Transition: Abbas Kazimi Appointed as New CEO

4 months ago talkbio0Tagged Abbas Kazimi, Biotechnology, CEO, computational drug discovery, Nimbus, Transition Mutation

Nimbus Therapeutics, CEO transition, Abbas Kazimi, Jeb Keiper, biotechnology, computational drug discovery

Callio Therapeutics Debuts with $187M to Develop Next-Generation Multi-Payload ADCs for Cancer

4 months ago talkbio0Tagged ADCs, Antibody-Drug, Biotechnology, Cancer Therapeutic Procedure, dual-payload technology, HER2-targeted therapy, Immunostimulating conjugate (antigen), multi-payload, Neoplasms

Multi-payload ADCs, antibody-drug conjugates, oncology, HER2-targeted therapy, dual-payload technology, cancer treatment, biotechnology startup

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

5 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures

Allakos Discontinues AK006 Development, Cuts 75% of Workforce Amid Strategic Restructuring

5 months ago talkbio0Tagged AK006, Allakos, Biotechnology, Chronic Spontaneous Urticaria, Failure (biologic function), Financial cost, phase 1 trial, restructuring, strategic alternatives

Allakos, AK006, workforce reduction, strategic alternatives, Phase 1 trial failure, chronic spontaneous urticaria (CSU), biotechnology, restructuring costs.

Retro Biosciences, Backed by Sam Altman, Seeks $1 Billion to Extend Human Lifespan by 10 Years

5 months ago talkbio0Tagged Altman, Artificial (qualifier value), Biosciences, Biotechnology, Dorsal, Funding, Health care facility, Homo sapiens, Intelligence, Lifespan Extension, Series

Retro Biosciences, Sam Altman, Human Lifespan Extension, Biotechnology, Series A Funding, Artificial Intelligence in Healthcare

Neomorph Secures $1.6 Billion Deal with AbbVie to Develop Molecular Glue Degraders for Oncology and Immunology

5 months ago talkbio0Tagged AbbVie, Biotechnology, Drug Development, Immunology, molecular glue, Neomorph, Neoplasms, pharmaceutical partnership, Protein Degradation, Metabolic

Neomorph, AbbVie, molecular glue degraders, oncology, immunology, protein degradation, drug development, biotechnology, pharmaceutical partnership.

Chinese Vaccine Biotech Ab&B Files for IPO, Drawing Attention from GSK, Merck, and Pfizer

5 months ago talkbio0Tagged Ab&B, Bio-Tech, Biotechnology, Chinese vaccine, Drug Industry, IPO, Pfizer, Pfizer/, SmithKline Beecham

Ab&B Bio-Tech, IPO, Chinese vaccine biotech, GSK, Merck, Pfizer, biotechnology, pharmaceutical industry

Neomorph Secures Third Major Collaboration with AbbVie for Molecular Glue Degraders Worth Up to $1.64 Billion

5 months ago talkbio0Tagged AbbVie, Biotechnology, Immunology, molecular glue, Neomorph, Neoplasms, pharmaceutical collaboration, Protein Degradation, Metabolic

Neomorph, AbbVie, molecular glue degraders, protein degradation, oncology, immunology, biotechnology, pharmaceutical collaboration

Chinese Biotechs Flock to Hong Kong IPOs for Next Growth Phase

5 months ago talkbio0Tagged Bay Area, Biotechnology, Chinese biotechs, Greater, HKEX, IPOs, Kong, listing reforms, Listings

Chinese biotechs, Hong Kong IPOs, biotechnology, pharmaceuticals, listing reforms, HKEX, Chapter 18A, biotech listings, Greater Bay Area.